UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 245.

A

Attygalle, AD; Kyriakou, C; Dupuis, J; Grogg, KL; Diss, TC; Wotherspoon, AC; Chuang, SS; ... Dogan, A; + view all (2007) Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: Clinical correlation and insights into natural history and disease progression. AMERICAN JOURNAL OF SURGICAL PATHOLOGY , 31 (7) pp. 1077-1088. 10.1097/PAS.0b013e31802d68e9.

Austin, S; Cohen, H; Losseff, N; (2007) Haematology and neurology. J NEUROL NEUROSUR PS , 78 (4) 334 - 341. 10.1136/jnnp.2006.092023.

Austin, SK; Davidson, SJ; Lawrie, AS; Mackie, IJ; Machin, SJ; (2007) Pronounced reduction in ADAMTS13 activity occurs in heparin induced thrombocytopenia but is not due to IgG ANTI-ADAMTS13. In: BLOOD. (pp. 621A - 621A). AMER SOC HEMATOLOGY

Austin, SK; Nash, ML; Peebles, D; Cohen, H; (2007) Successful management of late obstetric complications in the antiphospholipid syndrome. In: CLIN EXP RHEUMATOL. (pp. 156 - 156). CLINICAL & EXPER RHEUMATOLOGY

Austin, SK; Starke, RD; Lawrie, AS; Cohen, H; Machin, SJ; Mackie, IJ; (2007) ADAMTS13 dysfunction and anti-ADAMTS13 antibodies in the antiphospholipid syndrome (APS). CLIN EXP RHEUMATOL , 25 (2) 162 - 163.

B

Barkley, LR; Hong, HK; Kingsbury, SR; James, M; Stoeber, K; Williams, GH; (2007) Cdc6 is a rate-limiting factor for proliferative capacity during HL60 cell differentiation. EXP CELL RES , 313 (17) 3789 - 3799. 10.1016/j.yexcr.2007.07.004.

Bartoli, M; Poupiot, J; Vulin, A; Fougerousse, F; Arandel, L; Daniele, N; Roudaut, C; ... Richard, I; + view all (2007) AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency. Gene Ther , 14 (9) pp. 733-740. 10.1038/sj.gt.3302928.

Benjamin, R; Khwaja, A; Singh, N; McIntosh, J; Meager, A; Wadhwa, M; Streck, C; ... Nathwani, AC; + view all (2007) Continuous delivery of human type I interferons (alpha/beta) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model. BLOOD , 109 (3) 1244 - 1247. 10.1182/blood-2006-02-002915.

Benjamin, R; Singh, N; McIntosh, J; Meager, A; Wadhwa, M; Streck, C; Ng, C; ... Nathwani, AC; + view all (2007) Continuous delivery of human type I interferons ({alpha}/{beta}) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model. Blood , 109 (3) pp. 1244-1247.

Bennett, CL; Clausen, BE; (2007) DC ablation in mice: promises, pitfalls, and challenges. TRENDS IMMUNOL , 28 (12) 525 - 531. 10.1016/j.it.2007.08.011.

Bennett, CL; Noordegraaf, M; Martina, CAE; Clausen, BE; (2007) Langerhans cells are required for efficient presentation of topically applied hapten to T cells. JOURNAL OF IMMUNOLOGY , 179 (10) pp. 6830-6835. 10.4049/jimmunol.179.10.6830.

Bergamini, G; Cigana, C; Sorio, C; Della Peruta, M; Assael, BM; Melotti, P; (2007) Azithromycin decreases glutathione-stransferase T1 (GSTT1) and M1 (GSTM1) expression and activity in cystic fibrosis airway epithelial cells. PEDIATR PULM 297 - 297.

Berger, L; Hughes, D; Milligan, A; Mehta, A; (2007) Renal cysts in Fabry disease: Searching for the significance. Presented at: UNSPECIFIED.

Bergoglio, V; Larcher, F; Chevallier-Lagente, O; Bernheim, A; Danos, O; Sarasin, A; Rio, MD; (2007) Safe selection of genetically manipulated human primary keratinocytes with very high growth potential using CD24. Mol Ther , 15 (12) pp. 2186-2193. 10.1038/sj.mt.6300292.

Bishton, MJ; Lush, RJ; Byrne, JL; Russell, NH; Shaw, BE; Haynes, AP; (2007) Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease. BRIT J HAEMATOL , 136 (5) 752 - 761. 10.1111/j.1365-2141.2007.06498.x.

Blincoe, M; Bruce, R; Goodwin, S; Hughes, D; Milligan, A; Richfield, L; Mehta, AB; (2007) Gaucher disease: bone and joint complications in a cohort of UK patients. Presented at: UNSPECIFIED.

Bochtler, W; Maiers, M; Oudshoorn, M; Marsh, SGE; Raffoux, C; Mueller, C; Hurley, CK; (2007) World Marrow Donor Association guidelines for use of HLA nomenclature and its validation in the data exchange among hematopoietic stem cell donor registries and cord blood banks. Bone Marrow Transplant , 39 (12) pp. 737-741. 10.1038/sj.bmt.1705672.

Bochtler, W; Maiers, M; Oudshoorn, M; Marsh, SGE; Raffoux, C; Müller, C; Hurley, CK; (2007) World Marrow Donor Association Guidelines for use of HLA Nomenclature and its validation in the data exchange among hematopoietic stem cell donor registries and cord blood banks. Bone Marrow Transplantation , 39 pp. 737-741.

Brenes, O; Arce, F; Gaetjens-Boniche, O; Diaz, C; (2007) Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. BIOMEDICINE & PHARMACOTHERAPY , 61 (6) pp. 347-355. 10.1016/j.biopha.2007.02.007.

Brouns, R; Sheorajpanday, R; Braxel, E; Eyskens, F; Baker, R; Hughes, D; Mehta, A; ... De Deyn, PP; + view all (2007) Middelheim Fabry Study (MiFaS): A retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke. CLINICAL NEUROLOGY AND NEUROSURGERY , 109 (6) pp. 479-484. 10.1016/j.clineuro.2007.03.008.

Bustamante, J; Aksu, G; Vogt, G; De Beaucoudrey, L; Genel, F; Chapgier, A; Filipe-Santos, O; ... Casanova, J-L; + view all (2007) BCG-osis and tuberculosis in a child with chronic granulomatous disease. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , 120 (1) pp. 32-38. 10.1016/j.jaci.2007.04.034.

Bustamante, J; Picard, C; Fieschi, C; Filipe-Santos, O; Feinberg, J; Perronne, C; Chapgier, A; ... Casanova, J-L; + view all (2007) A novel X-linked recessive form of Mendelian susceptibility to mycobaterial disease. JOURNAL OF MEDICAL GENETICS , 44 (2) 10.1136/jmg.2006.043406.

Béroud, C; Tuffery-Giraud, S; Matsuo, M; Hamroun, D; Humbertclaude, V; Monnier, N; Moizard, M-P; ... Claustres, M; + view all (2007) Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy. Hum Mutat , 28 (2) pp. 196-202. 10.1002/humu.20428.

C

Cano, P; Klitz, W; Mack, SJ; Maiers, M; Marsh, SGE; Noreen, H; Reed, EF; ... Fernandez-Vina, M; + view all (2007) Common and well-documented HLA alleles - Report of the ad-hoc committee of the American Society for Histocompatiblity and Immunogenetics. HUMAN IMMUNOLOGY , 68 (5) pp. 392-417. 10.1016/j.humimm.2007.01.014.

Cappellini, MD; Bejaoui, M; Agaoglu, L; Porter, J; Coates, T; Jeng, M; Lai, ME; ... Baladi, JF; + view all (2007) Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia. CLIN THER , 29 (5) 909 - 917. 10.1016/j.clinthera.2007.05.007.

Cappellini, MD; Vichinsky, E; Ford, JM; Rabault, B; Porter, J; (2007) Evaluation of deferasirox (Exjade (R), ICL670) therapy in patients with transfusional iron overload who achieve serum ferritin (SF) <= 1000 ng/mL in long-term studies. In: BLOOD. (pp. 16B - 16B). AMER SOC HEMATOLOGY

Cappellini, MD; Vichinsky, E; Galanello, R; Piga, A; Williamson, P; Porter, JB; (2007) Long-term treatment with deferasirox (Exjade (R), ICL670), a once-daily oral iron chelator, is effective in patients with transfusion-dependent anemias. In: BLOOD. (pp. 816A - 816A). AMER SOC HEMATOLOGY

Chakraverty, R; Flutter, B; Eom, H; Zhao, G; Sykes, M; (2007) Clonal expansion is of graft-versus-host reactive CD8+ T cells is dissociated from full effector diffrentiation. In: (Proceedings) American Society of Haematology.

Chakraverty, R; Manji, N; Clark, R; Crawley, C; Johnson, P; Liakopoulou, E; Marsh, J; ... Mackinnon, S; + view all (2007) Multi-Center Phase II Study of CAMPATH-1H Dose De-Escalation Prior to Nonmyeloablative HLA-Identical Sibling Transplantation. In: (Proceedings) American Society of Haematology.

Chakraverty, R; Manji, N; Clark, R; Crawley, C; Johnson, P; Liakopoulou, E; Marsh, J; ... Mackinnon, S; + view all (2007) Multi-center phase II study of CAMPATH-1H dose de-escalation prior to nonmyeloablative HLA-identical sibling transplantation. In: BLOOD. (pp. 319A - 320A). AMER SOC HEMATOLOGY

Chakraverty, R; Sykes, M; (2007) The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukeryiia. BLOOD , 110 (1) 9 - 17. Gold open access

Charrier, S; Dupre, L; Scaramuzza, S; Jeanson-Leh, L; Blundell, MP; Danos, O; Cattaneo, F; ... Galy, A; + view all (2007) Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients. Gene Ther. , 14 (5) pp. 415-428.

Charrier, S; Dupré, L; Scaramuzza, S; Jeanson-Leh, L; Blundell, MP; Danos, O; Cattaneo, F; ... Galy, A; + view all (2007) Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients. Gene Therapy , 14 (5) pp. 415-428. 10.1038/sj.gt.3302863.

Chi, C; Riddell, A; Griffioen, A; Tuddenham, EG; Kadir, RA; (2007) Bleeding score as a screening tool for the identification and assessment of von Willebrand disease in women. In: THROMBOSIS RESEARCH. (pp. S101 - S101). PERGAMON-ELSEVIER SCIENCE LTD

Cole, AL; Lee, PJ; Hughes, DA; Deegan, PB; Waldek, S; Lachmann, RH; (2007) Depression in adults with Fabry disease: A common and under-diagnosed problem. J INHERIT METAB DIS , 30 (6) 943 - 951. 10.1007/s10545-007-0708-6.

Cotton, RGH; 2006 Human Variome Project, ; Appelbe, W; Auerbach, AD; Becker, K; Bodmer, W; Boone, DJ; ... Watson, M; + view all (2007) Recommendations of the 2006 Human Variome Project meeting. Nat Genet , 39 (4) pp. 433-436. 10.1038/ng2024.

Cox-Brinkman, J; Vedder, A; Hollak, C; Richfield, L; Mehta, A; Orteu, K; Wijburg, F; (2007) Three -dimensional face shape in Fabry disease. European Journal of Human Genetics , 15 (5) pp. 535-542.

Craddock, C; Chakraverty, R; (2007) Stem Cell Transplantation. In: Postgraduate Haematology: Fifth Edition. (pp. 419-435).

Craddock, CF; Tauro, S; Gregory, JE; Buckley, L; Ward, J; Kottaridis, P; Thelouli, E; ... Russell, NH; + view all (2007) Factors predicting long term survival after reduced intensity allogeneic stem cell transplantation in acute myeloid leukemia. In: BLOOD. (pp. 103A - 103A). AMER SOC HEMATOLOGY

D

D'Sa, S.P.; (2007) Immune reconstitution of B cell and T cell compartments following reduced intensity allogeneic stem cell transplantation for myeloma. Doctoral thesis , University of London. Green open access
file

Das-Gupta, EP; Russell, NH; Shaw, BE; Pearce, RM; Byrne, JL; (2007) Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant alemtuzumab. BIOL BLOOD MARROW TR , 13 (6) 724 - 733. 10.1016/j.bbmt.2007.02.011.

Delgado, J; Pillai, S; Benjamin, R; Caballero, D; Martino, R; Lovell, R; Thomson, K; ... Mackinnon, S; + view all (2007) The effect of in vivo T-cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia. In: BLOOD. (pp. 885A - 885A). AMER SOC HEMATOLOGY

Devy, L; Rabbani, SA; Stochl, M; Ruskowski, M; Mackie, I; Naa, L; Toews, M; ... Henderikx, P; + view all (2007) PEGylated DX-1000: Pharmacokinetics and antineoplastic activity of a specific plasmin inhibitor. NEOPLASIA , 9 (11) 927 - 937. 10.1593/neo.07544. Gold open access

Dickson, PV; Hamner, JB; Streck, CJ; Ng, CYC; McCarville, MB; Calabrese, C; Glibertson, RJ; ... Davidoff, AM; + view all (2007) Continuous delivery of IFN-beta promotes sustained maturation of intratumoral vasculature. MOL CANCER RES , 5 (6) 531 - 542. 10.1158/1541-7786.MCR-06-0259.

Dimopoulou, MN; Gandhi, S; Ghevaert, C; Chakraverty, R; Fielding, A; Webster, D; Mackinnon, S; (2007) Successful treatment of autoimmune lymphoproliferative syndrome and refractory autoimmune thrombocytopenic purpura with a reduced intensity conditioning stem cell transplantation followed by donor lymphocyte infusion. BONE MARROW TRANSPL , 40 (6) 605 - 606. 10.1038/sj.bmt.1705775.

E

Evans, P; Porter, J; (2007) Contrasting detectability of non-transferrin-bound iron (NTBI) species by bleomycin and other assays: Implications for speciation of NTBI. AM J HEMATOL , 82 (6) 558 - 559.

F

Fielding, AK; (2007) Be careful what you wish for? BLOOD , 109 (7) pp. 2673-2674.

Fielding, AK; Richards, SM; Chopra, R; Lazarus, HM; Litzow, MR; Buck, G; Durrant, IJ; ... Goldstone, AH; + view all (2007) Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood , 109 (3) pp. 944-950. 10.1182/blood-2006-05-018192.

Fielding, AK; Richards, SM; Chopra, R; Lazarus, HM; Litzow, MR; Buck, G; Durrant, IJ; ... Eastern Cooperative Oncology Grp, ; + view all (2007) Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. BLOOD , 109 (3) 944 - 950. 10.1182/blood-2006-05-018192.

Fielding, AK; Richards, SM; Lazarus, HM; Litzow, MR; Luger, SM; Marks, DI; McMillan, AK; ... Goldstone, AH; + view all (2007) Does imatinib change the outcome in philapdelphia chromosome positive acute lympooblastic leukaemia in adults? Data from the UKALLXII/ECOG2993 study. In: BLOOD. (pp. 10A - 10A). AMER SOC HEMATOLOGY

Fougerousse, F; Bartoli, M; Poupiot, J; Arandel, L; Durand, M; Guerchet, N; Gicquel, E; ... Richard, I; + view all (2007) Phenotypic correction of alpha-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector. Mol Ther , 15 (1) pp. 53-61. 10.1038/sj.mt.6300022.

Fung, EB; Harmatz, P; Milet, M; Ballas, SK; De Castro, L; Hagar, W; Owen, W; ... Vichinsky, E; + view all (2007) Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload. AMERICAN JOURNAL OF HEMATOLOGY , 82 (4) pp. 255-265. 10.1002/ajh.20809.

G

GUPTA, R; Hong, D; Iborra, F; Sarno, S; (2007) NOV (CCN3) Functions as a Regulator of Human Hematopoietic Stem or Progenitor Cells. Science , 316 (5824) pp. 590-593. 10.1126/science.1136031.

Gale, RE; Allen, AJR; Nash, MJ; Linch, DC; (2007) Long-term serial analysis of X-chromosome inactivation patterns and JAK2 V617F mutant levels in patients with essential thrombocythemia show that minor mutant-positive clones can remain stable for many years. BLOOD , 109 (3) 1241 - 1243. 10.1182/blood-2006-06-029769.

Gale, RE; Hills, R; Wheatley, K; Burnett, AK; Linch, DC; (2007) Still a need for more robust evidence that FLT3/ITD status should influence the decision to proceed to transplantation in AML patients. BLOOD , 109 (5) 2265 - 2265.

Gardiner, C; Cohen, H; Machin, SJ; Mackie, IJ; (2007) 29 Pregnancy morbidity, tissue factor pathway inhibitor deficiency and resistance to activated protein C. Presented at: UNSPECIFIED.

Gardiner, C; Cohen, H; Machin, SJ; Mackie, IJ; (2007) Pregnancy morbidity, tissue factor pathway inhibitor deficiency and resistance to activated protein C. In: THROMBOSIS RESEARCH. (pp. S104 - S105). PERGAMON-ELSEVIER SCIENCE LTD

Gisselbrecht, C; Schmitz, N; Mounier, N; Ma, D; Tmeny, M; Hagberg, H; Linch, DC; ... Moskowitz, C; + view all (2007) R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by stem cell transplantation and maintenance treatment with rituximab or not: First interim analysis on 200 patients. CORAL study. In: BLOOD. (pp. 159A - 159A). AMER SOC HEMATOLOGY

Glassford, J; Rabin, N; Lam, EWF; Yong, KL; (2007) Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells. BRIT J HAEMATOL , 139 (2) 243 - 254. 10.1111/j.1365-2141.2007.06789.x.

Grandage, V.L.; (2007) Investigation of aberrant signal transduction in acute myeloid leukaemia. Doctoral thesis , University of London. Green open access
file

Gupta, M; Raghavan, M; Gale, RE; Chelala, C; Allen, C; Molloy, G; Chaplin, T; ... Young, B; + view all (2007) A genome-wide map of acquired uniparental disomy in acute myeloid leukemia. In: BLOOD. (pp. 302A - 302A). AMER SOC HEMATOLOGY

Gupta, R; Hong, D; Iborra, F; Sarno, S; Enver, T; (2007) NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells. SCIENCE , 316 (5824) pp. 590-593. 10.1126/science.1136031.

H

Hart, DP; Peggs, KS; (2007) Current status of allogeneic stem cell transplantation for treatment of hematologic malignancies. CLIN PHARMACOL THER , 82 (3) 325 - 329. 10.1038/sj.clpt.6100283.

Hoffmann, B; Beck, M; Sunder-Plassmann, G; Borsini, W; Ricci, R; Mehta, A; (2007) Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy - A retrospective analysis from the Fabry outcome survey. CLINICAL JOURNAL OF PAIN , 23 (6) pp. 535-542. 10.1097/AJP.0b013e318074c986.

Hoffmann, B; Schwarz, M; Mehta, A; Keshav, S; (2007) Gastrointestinal symptoms in 342 patients with Fabry disease: Prevalence and response to enzyme replacement therapy. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , 5 (12) pp. 1447-1453. 10.1016/j.cgh.2007.08.012.

Hollak, CEM; Biegstraaten, M; Van Schaik, IN; Mengel, E; Marodi, L; Petakov, M; Niederau, C; ... Mehta, A; + view all (2007) Prevalence of polyneuropathy in adult type 1 Gaucher disease (GD1): A multinational prospective observational study. Presented at: UNSPECIFIED.

Hollak, CEM; Marodi, L; Biegstraaten, M; Van Schaik, IN; Niederau, C; Hughes, D; Giraldo, P; (2007) A prospective study of neurological manifestations and other comorbidities in adult type I Gaucher disease. Presented at: 3rd Annual World Symposium on Lysosomal Disease Networks, Orlando, FL.

Hough, R; Labopin, M; Michel, G; Locatelli, F; Klingebiel, T; Arcese, W; Fagioli, F; ... Rocha, V; + view all (2007) Outcomes of fully haploidentical hernatopoietic stem cell transplantation compared to unrelated cord blood transplantation in children with acute lymphoblastic leukaemia. A retrospective analysis on behalf of Eurocord, Pediatric disease and Acute Leukemia Working Party of EBMT. In: (Proceedings) 47th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 39). WILEY-BLACKWELL

Huang, KM; Wu, J; Brooks, SP; Hardcastle, AJ; Lewis, RA; Stambolian, D; (2007) Identification of three novel NHS mutations in families with Nance-Horan syndrome. Mol Vis , 27 (13) pp. 470-474.

Hughes, D; Cappellini, MD; Bergen, MG; Van Droogenbroeck, J; de Fost, M; Janic, D; Marinakis, T; ... Hollaks, C; + view all (2007) Haematological and onco-haematological aspects of Gaucher disease: Consensus recommendations for treatment and disease management. Presented at: 12th Congress of the European-Hematology-Association, Vienna, AUSTRIA.

Hughes, D; Cappellini, MD; Berger, M; Van Droogenbroeck, J; de Fost, M; Janic, D; Marinakis, T; ... Hollak, C; + view all (2007) Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease. BRIT J HAEMATOL , 138 (6) 676 - 686. 10.1111/j.1365-2141.2007.06701.x.

Hughes, DA; Ginsberg, L; Baker, R; Goodwin, S; Milligan, A; Richfield, L; Mehta, AB; (2007) Effective treatment of an elderly patient with Gaucher's disease and Parkinsonism: A case report of 24 months' oral substrate reduction therapy with miglustat. PARKINSONISM & RELATED DISORDERS , 13 (6) pp. 365-368. 10.1016/j.parkreldis.2006.07.01.

Hughes, DA; Ginsberg, L; Baker, R; Goodwin, S; Milligan, A; Richfield, L; Mehta, AB; (2007) Effective treatment of an elderly patient with Gaucher's disease and Parkinsonism: a case report of 24 months' oral substrate reduction therapy with miglustat. Parkinsonism and Related Disorders , 13 (6) 365 - 368.

Hughes, DA; Ginsberg, L; Baker, R; Goodwin, S; Milligan, A; Richfield, L; Mehta, AB; (2007) Effective treatment of an elderly patient with Gaucher's disease and Parkinsonism: a case report of 24 months' oral substrate reduction therapy with miglustat. Parkinsonism Relat Disord , 13 (6) 365 - 368. 10.1016/j.parkreldis.2006.07.010.

Hughes, DA; Hollak, CEM; Schwierin, B; Bembi, B; (2007) Post-marketing surveillance of miglustat in type 1 Gaucher disease (GD1). J INHERIT METAB DIS , 30 119 - 119.

Hughes, DA; Milligan, AMAB; (2007) Home therapy for lysosomal storage disorders. British Journal of Nursing , 16 (22) pp. 1384-1389.

Hughes, DA; Reed, MC; Baker, RJ; Richfield, L; Milligan, A; Evans, S; Blincoe, M; (2007) Enhanced differentiation of osteoclasts from circulating mononuclear precursors in patients with Gaucher disease. ACTA PAEDIATR , 96 106 - 106.

Hurley, CK; Maiers, M; Marsh, SGE; Oudshoorn, M; (2007) Overview of registries, HLA typing and diversity, and search algorithms. TISSUE ANTIGENS , 69 pp. 3-5. 10.1111/j.1399-0039.2006.758_2.x.

I

Idowu, BD; Al-Adnani, M; O'Donnell, P; Yu, L; Odell, E; Diss, T; Gale, RE; (2007) A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone. HISTOPATHOLOGY , 50 (6) 691 - 704. 10.1111/j.1365-2559.2007.02676.x.

Idowu, BD; Mangion, J; Gale, RE; Flanagan, AM; (2007) Genetic mutations in the ras/raf/mapkinase pathway results in cherubism. In: JOURNAL OF BONE AND MINERAL RESEARCH. (pp. 1124 - 1124). AMER SOC BONE & MINERAL RES

Idowu, BD; Mangion, J; Gale, RE; Flanagan, AM; (2007) SH3BP2, PTPN11 and NF1 mutations resulting in the cherubism phenotype. In: BONE. (pp. S160 - S161). ELSEVIER SCIENCE INC

Israeli, D; Ziaei, S; Gjata, B; Benchaouir, R; Rameau, P; Marais, T; Fukada, S-I; ... Garcia, L; + view all (2007) Expression of mdr1 is required for efficient long term regeneration of dystrophic muscle. Exp Cell Res , 313 (11) pp. 2438-2450. 10.1016/j.yexcr.2007.02.036.

J

Jalal, H; Bibby, DF; Bennett, J; Sampson, RE; Brink, NS; MacKinnon, S; Tedder, RS; (2007) Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit. J CLIN MICROBIOL , 45 (6) 1690 - 1696. 10.1128/JCM.01912-06. Gold open access

Jouanguy, E; Zhang, S-Y; Chapgier, A; Sancho-Shimizu, V; Puel, A; Picard, C; Boisson-Dupuis, S; ... Casanova, J-L; + view all (2007) Human primary immunodeficiencies of type I interferons. BIOCHIMIE , 89 (6-7) pp. 878-883. 10.1016/j.biochi.2007.04.016.

K

Kariyawasan, CC; Hughes, DA; Jayatillake, MM; Mehta, AB; (2007) Multiple myeloma: causes and consequences of delay in diagnosis. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE , 100 (10) pp. 635-640. 10.1093/qjmed/hcm077.

Kichler, A; Leborgne, C; Danos, O; Bechinger, B; (2007) Characterization of the gene transfer process mediated by histidine-rich peptides. J Mol Med (Berl) , 85 (2) pp. 191-201. 10.1007/s00109-006-0119-4.

Kogelberg, H; Tolner, B; Sharma, SK; Lowdell, MW; Qureshi, U; Robson, M; Hillyer, T; (2007) Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy (vol 17, pg 36, 2007). GLYCOBIOLOGY , 17 (10) 1030 - 1030. 10.1093/glycob/cw1053.

Kogelberg, H; Tolner, B; Sharma, SK; Lowdell, MW; Qureshi, U; Robson, M; Hillyer, T; ... Chester, KA; + view all (2007) Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy. GLYCOBIOLOGY , 17 (1) 36 - 45. 10.1093/glycob/cwl053.

Kyriakou, C; Canals, C; Sureda, A; Taghipour, G; Cornelissen, J; Willemze, R; Socie, G; ... Schmitz, N; + view all (2007) Allogeneic stem cell transplantation (Allo-SCT) in the management of advanced waldenstrom's macroglobulinemia (WM). In: (Proceedings) 49th Annual Meeting of the American-Society-of-Hematology. (pp. 191A-191A). AMER SOC HEMATOLOGY

Kyriakou, C; Canals, C; Sureda, A; Taghipour, G; Gisselbrecht, C; Mazza, P; Montserrat, E; ... Schmitz, N; + view all (2007) The role of autologous stem cell transplantation (ASCT) in patients with advanced Waldenstrom's macroglobulinemia. In: (Proceedings) 49th Annual Meeting of the American-Society-of-Hematology. (pp. 286A-286A). AMER SOC HEMATOLOGY

Kyriakou, C; Canals, C; Taghipour, G; Finke, J; Kolb, H; Goldstone, A; Sureda, A; (2007) Allogeneic stem cell transplantation in angioimmunoblastic T-cell lymphoma (AITL): A retrospective survey from the lymphoma working party (LWP) of the European group for blood and marrow transplantation (EBMT). In: (Proceedings) 49th Annual Meeting of the American-Society-of-Hematology. (pp. 894A-894A). AMER SOC HEMATOLOGY

Kyriakou, C; Kyriakou, C; Canals, C; Taghipour, G; Comelissen, J; Willemze, R; Socie, G; ... Schmitz, N; + view all (2007) Allogeneicstem cell transplantation for patients with Waldenstrms Macroglobulinaemia. Analysis of 106 cases from the European bone marrow registry (EBMT). In: (Proceedings) 12th Congress of the European-Hematology-Association. (pp. p. 133). FERRATA STORTI FOUNDATION

Kyriakou, C; Kyriakou, C; Canals, C; Taghipour, G; Gisselbrecht, C; Mazza, P; Kazmi, M; ... Schmitz, N; + view all (2007) The role for autologous stem cell transplantation (ASCT) in the treatment of waldenstrms macroglobulinaemia patients. Analysis of 201 cases from the European bone marrow transplant registry (EBMT). In: (Proceedings) 12th Congress of the European-Hematology-Association. (pp. p. 157). FERRATA STORTI FOUNDATION

L

Lambert, J; Austin, S; Peebles, D; Cohen, H; (2007) Managing peri-delivery anticoagulation in women on therapeutic dose low-molecular weight heparin: a role for unfractionated heparin. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 85 - 85). BLACKWELL PUBLISHING

Lambert, J; Cooper, N; Bomanji, J; Ell, P; Mackinnon, S; (2007) The use of 18F-FDG PET/CT to direct immunotherapy following reduced-intensity stem cell transplants in adults with lymphoid malignancies. In: BONE MARROW TRANSPLANTATION. (pp. S41 - S41). NATURE PUBLISHING GROUP

Laurson, J; Selden, C; Clements, M; Mavri-Damelin, D; Coward, S; Lowdell, M; Hodgson, HJF; (2007) Putative human liver progenitor cells in explanted liver. Cells Tissues Organs , 186 (3) pp. 180-191. 10.1159/000106360.

Laurson, J; Selden, C; Clements, M; Mavri-Damelin, D; Coward, S; Lowdell, M; Hodgson, HJF; (2007) Putative human liver progenitor cells in explanted liver. CELLS TISSUES ORGANS , 186 (3) 180 - 191. 10.1159/000106360.

Lawrie, AS; Kobayashi, K; Tajima, K; Hoshiko, S; Matsuo, N; Hamaguchi, Y; Liesner, R; ... Mackie, IJ; + view all (2007) Evaluation of the CS-2000i analyser using coagulation, amidolytic and immuno-turbidometric assays. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 52 - 52). BLACKWELL PUBLISHING

Lindsey, WB; Lowdell, MW; Marti, GE; Abbasi, F; Zenger, V; King, KM; Lamb, LS; (2007) CD69 expression as an index of T-cell function: assay standardization, validation and use in monitoring immune recovery. CYTOTHERAPY , 9 (2) 123 - 132. 10.1080/14653240601182838.

Linhart, A; Kampmann, C; Zamorano, JL; Sunder-Plassmann, G; Beck, M; Mehta, A; Elliott, PM; (2007) Cardiac manifestations of Anderson-Fabry disease results from the international Fabry outcome survey. EUR HEART J , 28 (10) 1228 - 1235. 10.1093/eurheartj/ehm153.

Little, AM; Marsh, SGE; Madrigal, JA; (2007) Histocompatibility. In: Postgraduate Haematology: Fifth Edition. (pp. 395-418).

Longair, I; Pescott, MA; Erwin, H; Gardiner, C; Machin, SJ; Cohen, H; (2007) Improving uptake of patient self-testing in the anticoagulation clinic. Presented at: 47th Annual Scientific Meeting of the British-Society-for-Haematology, Bournemouth, ENGLAND.

Lowdell, MW; North, J; Bakhsh, I; Marden, C; Anderson, R; Pittman, H; Mackinnon, S; (2007) Tumor-activated human NK cells - Potential for "off-the-shelf" immunotherapy. In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. (pp. 14 - 14). ELSEVIER SCIENCE INC

Lowdell, MW; Thomson, K; Armoogum, J; Pang, K; Samuel, E; Desborough, M; Mackinnon, S; (2007) Direct isolation of donor-derived CMV-specific T-cells and their adoptive transfer for treatment or prophylaxis of CMV infection following allogeneic HSCT. In: BONE MARROW TRANSPLANTATION. (pp. S54 - S54). NATURE PUBLISHING GROUP

Lowdell, MW; Thomson, K; Julie, A; Pang, K; Samuel, E; Desborough, M; Mackinnon, S; (2007) Direct isolation and infusion of donor-derived CMV-specific T cells for treatment or prophylaxis of CMV infection following allogeneic transplantation. In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. (pp. 19 - 19). ELSEVIER SCIENCE INC

M

Machin, S; Longair, I; Gardiner, C; Mackie, I; Pescott, M; Erwin, H; Cohen, H; (2007) Acceptability and efficacy of oral anticoagulant self-testing for new patients attending the anticoagulation clinic. In: INT J LAB HEMATOL. (pp. 33 - 33). BLACKWELL PUBLISHING

Mackie, I; Cooper, P; Kitchen, S; (2007) Quality assurance issues and interpretation of assays. SEMIN HEMATOL , 44 (2) 114 - 125. 10.1053/j.seminhematol.2007.01.001.

Mackie, I; Lawrie, A; Kobayashi, K; Tajima, K; Hoshiko, S; Matsuo, N; Hamaguchi, Y; ... Machin, S; + view all (2007) An evaluation of the Sysmex CS-2000i coagulation analyzer. INT J LAB HEMATOL , 29 74 - 74.

Mackinnon, S; Thomson, KJ; Goldstone, AH; Linch, DC; Peggs, KS; (2007) Improved outcome following reduced intensity allogeneic transplantation in Hodgkin's lymphoma relapsing post-autologous transplantation. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 5 - 5). FERRATA STORTI FOUNDATION Gold open access

Madrigal, JA; Mayor, NP; Maldonado-Torres, H; Shaw, BE; Marsh, SGE; (2007) NOD2/CARD15 genotype and HLA-DPB1 matching status can be used to predict disease relapse in recipients of an unrelated donor haematopoietic stein cell transplant for acute leukaemia. In: BLOOD. (pp. 255A - 255A). AMER SOC HEMATOLOGY

Mafficini, A; Vezzalini, M; Zamai, L; Galeotti, L; Bergamini, G; Della Peruta, M; Melotti, P; (2007) Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors. Biomark Insights , 2 pp. 218-225. Gold open access

Maiers, M; Spellman, S; Marsh, SGE; Parham, P; Rajalingam, R; Reed, E; Noreen, H; ... Cooley, S; + view all (2007) A community standard reporting format for KIR genotyping data. In: (Proceedings) 33rd Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics. (pp. S105-S105). ELSEVIER SCIENCE INC

Mansour, M; Duke, V; Patel, B; Ancliff, P; Foroni, L; Gale, RE; Linch, DC; (2007) Analysis of paired presentation and relapse samples in T-ALL suggests that, at least in some patients, Notch-1 mutations may be acquired as a secondary event. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 326 - 326). FERRATA STORTI FOUNDATION Gold open access

Mansour, MR; Duke, V; Foroni, L; Patel, B; Allen, CG; Ancliff, PJ; Gale, RE; (2007) Notch-1 mutations are secondary events in some patients with T-Cell acute lymphoblastic leukemia. CLIN CANCER RES , 13 (23) 6964 - 6969. 10.1158/1078-0432.CCR-07-1474.

Marsh, SG; (2007) Nomenclature for factors of the HLA system, update September 2007. TISSUE ANTIGENS , 70 (6) pp. 534-535. 10.1111/j.1399-0039.2007.00960.x.

Marsh, SGE; (2007) Nomenclature for factors of the HLA system, update April 2007. TISSUE ANTIGENS , 70 (2) pp. 174-176. 10.1111/j.1399-0039.2007.00887.x.

Marsh, SGE; (2007) Nomenclature for factors of the HLA system, update August 2007. TISSUE ANTIGENS , 70 (6) pp. 531-533. 10.1111/j.1399-0039.2007.00941.x.

Marsh, SGE; (2007) Nomenclature for factors of the HLA system, update December 2006. TISSUE ANTIGENS , 69 (3) pp. 290-292. 10.1111/j.1399-0039.2007.00807.x.

Marsh, SGE; (2007) Nomenclature for factors of the HLA system, update February 2007. TISSUE ANTIGENS , 70 (1) pp. 80-82. 10.1111/j.1399-0039.2007.00847.x.

Marsh, SGE; (2007) Nomenclature for factors of the HLA system, update January 2007. TISSUE ANTIGENS , 69 (6) pp. 623-625. 10.1111/j.1399-0039.2007.00832.x.

Marsh, SGE; (2007) Nomenclature for factors of the HLA system, update July 2007. TISSUE ANTIGENS , 70 (5) pp. 445-447. 10.1111/j.1399-0039.2007.00934.x.

Marsh, SGE; (2007) Nomenclature for factors of the HLA system, update June 2007. TISSUE ANTIGENS , 70 (4) pp. 352-353. 10.1111/j.1399-0039.2007.00911.x.

Marsh, SGE; (2007) Nomenclature for factors of the HLA system, update March 2007. TISSUE ANTIGENS , 70 (1) pp. 83-85. 10.1111/j.1399-0039.2007.00852.x.

Marsh, SGE; (2007) Nomenclature for factors of the HLA system, update May 2007. TISSUE ANTIGENS , 70 (3) pp. 263-264. 10.1111/j.1399-0039.2007.00903.x.

Marsh, SGE; (2007) Nomenclature for factors of the HLA system, update November 2006. TISSUE ANTIGENS , 69 (3) pp. 288-289. 10.1111/j.1399-0039.2007.00805.x.

Marsh, SGE; (2007) Nomenclature for factors of the HLA system, update October 2006. TISSUE ANTIGENS , 69 (3) pp. 286-287. 10.1111/j.1399-0039.2007.00804.x.

Maser, RS; Choudhury, B; Campbell, PJ; Feng, B; Wong, KK; Protopopov, A; O'Neil, J; ... DePinho, RA; + view all (2007) Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. NATURE , 447 (7147) 966 - U3. 10.1038/nature05886.

Mason, AJ; Leborgne, C; Moulay, G; Martinez, A; Danos, O; Bechinger, B; Kichler, A; (2007) Optimising histidine rich peptides for efficient DNA delivery in the presence of serum. J Control Release , 118 (1) pp. 95-104. 10.1016/j.jconrel.2006.12.004.

Masurier, C; Boutin, S; Veron, P; Bernard, J; Danos, O; Davoust, J; (2007) Enhanced lentiviral transduction of monocyte-derived dendritic cells in the presence of conditioned medium from dying monocytes. Hum Gene Ther , 18 (2) pp. 161-170. 10.1089/hum.2006.106.

Mayor, N; Shaw, B; Hughes, D; Maldonado-Torres, H; Madrigal, JA; Keshav, S; Marsh, SGE; (2007) Single nucleotide polymorphisms of the NOD2/CARD15 gene are associated with significant increases in disease relapse and death in recipients of an unrelated donor haematopoietic stem cell transplant for acute leukaemia. In: (Proceedings) 33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation. (pp. S1-S1). NATURE PUBLISHING GROUP

Mayor, NP; Shaw, BE; Hughes, DA; Maldonado-Torres, H; Madrigal, JA; Keshav, S; Marsh, SGE; (2007) NOD2/CARD15 gene single nucleotide polymorphisms are associated with significant increases in mortality due to increases in disease relapse in recipients of an unrelated donor haematopoietic stem cell transplant for acute leukaemia. In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. (pp. 25 - 25). ELSEVIER SCIENCE INC

Mayor, NP; Shaw, BE; Hughes, DA; Maldonado-Torres, H; Madrigal, JA; Keshav, S; Marsh, SGE; (2007) Single nucleotide Polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. JOURNAL OF CLINICAL ONCOLOGY , 25 (27) 4262 - 4269. 10.1200/JCO.2007.12.1897.

Mayor, NP; Shaw, BE; Hughes, DA; Maldonado-Torres, H; Madrigal, JA; Keshav, S; Marsh, SGE; (2007) Single nucleotide polymorphisms (SNPs) of the NOD2/CARD15 gene are associated with significant increases in disease relapse and death in recipients of an unrelated donor haematopoietic stem cell transplant for acute leukaemia. INT J IMMUNOGENET , 34 (4) 295 - 295.

Mayor, NP; Shaw, BE; Hughes, DA; Maldonado-Torres, H; Madrigal, JA; Keshav, S; Marsh, SGE; (2007) Single nucleotide polymorphisms (SNPs) of the NOD2CARD15 gene are associated with significant increases in disease relapse and death in recipients of an unrelated donor haematopoietic stem cell transplant for acute leukaemia. In: TISSUE ANTIGENS. (pp. 373 - 373). BLACKWELL PUBLISHING

Mayor, NP; Shaw, BE; Keshav, S; Madrigal, JA; Marsh, SGE; (2007) A novel technique for NOD2/CARD15 genotyping using PCR-SSP. J IMMUNOL METHODS , 327 (1-2) 82 - 87. 10.1016/j.jim.2007.07.013.

Mayor, NP; Shaw, BE; Keshav, S; Madrigal, JA; Marsh, SGE; (2007) A novel technique for NOD2/CARD15 genotyping using PCR-SSP. Journal of Immunological Methods , 327 pp. 82-87.

Mead, A; Khwaja, A; Kottaridis, P; Linch, D; Gale, R; (2007) Lestaurtinib induces increased cytotoxicity in primaryaml blasts with a FLT3 internal tandem duplication compared tothosewith wildtype or tyrosine kinase domain mutated FLT3. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 323 - 323). FERRATA STORTI FOUNDATION Gold open access

Mead, AJ; Linch, DC; Hills, RK; Wheatley, K; Burnett, AK; Gale, RE; (2007) FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia. BLOOD , 110 (4) 1262 - 1270. 10.1182/blood-2006-04-015826.

Mehta, AB; Hughes, DA; (2007) Lysosomal Storage Disorders. In: Postgraduate Haematology: Fifth Edition. (pp. 318-329).

Mehta, ALE; (2007) Access to Expensive drugs in the UK; Mythis and realities for cancer patients. International Journal of Clinical Practice , 61 (12) pp. 2126-2129.

Moorman, A; Harrison, CJ; Buck, GAN; Richards, SM; Secker-Walker, LM; Martineau, M; Vance, GH; ... Dewald, GW; + view all (2007) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 139 - 139). FERRATA STORTI FOUNDATION Gold open access

Moorman, AV; Harrison, CJ; Buck, GAN; Richards, SM; Secker-Walker, LM; Martineau, M; Vance, GH; ... Eastern Cooperative Oncology Grp, ; + view all (2007) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. BLOOD , 109 (8) 3189 - 3197. 10.1182/blood-2006-10-051912.

Moorman, AV; Harrison, CJ; Buck, GAN; Richards, SM; Secker-Walker, LM; Martineau, M; Vance, GH; ... Dewald, GW; + view all (2007) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia. In: (Proceedings) 47th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 1). BLACKWELL PUBLISHING

Moran, TP; Burgents, JE; Long, B; Ferrer, I; Jaffee, EM; Tisch, RM; Johnston, RE; (2007) Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice. Vaccine , 25 (36) pp. 6604-6612. 10.1016/j.vaccine.2007.06.058.

Morris, TC; Kettle, PJ; Drake, MB; Brunton, A; Cook, G; Leahy, M; O'Dwyer, M; ... Cavenagh, JD; + view all (2007) PAD given at relapse is more effective than VAD given as induction therapy - Results of a phase II study. In: (Proceedings) 49th Annual Meeting of the American-Society-of-Hematology. (pp. 800A-800A). AMER SOC HEMATOLOGY

Morris, TCM; Drake, M; Kettle, PJ; Brunton, A; Cook, G; Leahy, M; O'Dwyer, M; ... Cavenagh, J; + view all (2007) Pad in relapsed and refractory myeloma. a phase II study. In: (Proceedings) 11th International Myeloma Workshop/4th International Workshop on Wladenestroms Macroglobulinemia. (pp. p. 160). FERRATA STORTI FOUNDATION Gold open access

Muszlak, M; Chapgier, A; Harivelo, RB; Castella, C; Cremades, F; Goulois, E; Laporte, R; ... Picard, C; + view all (2007) Multifocal infection due to Mycobacterium intracellulare: first case of interferon gamma receptor partial dominant deficiency in tropical French territory. ARCHIVES DE PEDIATRIE , 14 (3) pp. 270-272. 10.1016/j.arcped.2006.11.023.

N

Nash, MJ; Cohen, H; Liesner, R; Machin, SJ; (2007) Acquired Coagulation Disorders and Vascular Bleeding. In: Postgraduate Haematology: Fifth Edition. (pp. 859-875).

Nathwani, A.C.; Gray, J.T.; McIntosh, J.; Ng, C.Y.C.; Zhou, J.; Spence, Y.; Cochrane, M.; ... Davidoff, A.M.; + view all (2007) Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates. Blood , 109 (4) pp. 1414-1421. 10.1182/blood-2006-03-010181.

Nathwani, AC; Gray, JT; McIntosh, J; Ng, CYC; Zhou, JF; Spence, Y; Cochrane, M; ... Davidoff, AM; + view all (2007) Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates. BLOOD , 109 (4) 1414 - 1421. 10.1182/blood-2006-03-010181. Gold open access

Nichols, LA; Chen, Y; Colella, TA; Bennett, CL; Clausen, BE; Engelhard, VH; (2007) Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes. JOURNAL OF IMMUNOLOGY , 179 (2) pp. 993-1003. 10.4049/jimmunol.179.2.993.

North, J; Bakhsh, I; Marden, C; Pittman, H; Addison, E; Navarrete, C; Anderson, R; (2007) Tumor-primed human natural killer cells lyse NK-resistant tumor targets: Evidence of a two-stage process in resting NK cell activation. J IMMUNOL , 178 (1) 85 - 94.

O

O'Malley, CMN; Frumento, RJ; Mackie, IJ; Gallimore, MJ; Hirsh, AL; Bennett-Guerrero, E; (2007) The role of endogenous kallikrein inhibition in perioperative transfusion and adverse outcome in cardiac surgical patients. J CARDIOTHOR VASC AN , 21 (1) 23 - 27. 10.1053/j.jvca.2006.07.015.

Oakervee, H; Popat, R; Cavenagh, JD; (2007) Use of bortezomib as induction therapy prior to stem cell transplantation in frontline treatment of multiple myeloma: Impact on stem cell harvesting and engraftment. LEUKEMIA & LYMPHOMA , 48 (10) pp. 1910-1921. 10.1080/10428190701540991.

Oakervee, H; Popat, R; Hamblin, M; Rule, S; Rahemtulla, A; Cavenagh, J; (2007) Longterm follow up of T-VAD for untreated multiple myeloma. In: (Proceedings) 11th International Myeloma Workshop/4th International Workshop on Wladenestroms Macroglobulinemia. (pp. pp. 177-178). FERRATA STORTI FOUNDATION Gold open access

Orteu, CH; Jansen, T; Lidove, O; Jaussaud, R; Hughes, DA; Pintos-Morell, G; Ramaswami, U; ... Mehta, AB; + view all (2007) Fabry disease and the skin: data from FOS, the Fabry outcome survey. BRITISH JOURNAL OF DERMATOLOGY , 157 (2) pp. 331-337. 10.1111/j.1365-2133.2007.08002.x.

Orteu, CH; Jansen, T; Lidove, O; Jaussaud, R; Hughes, DA; Pintos-Morell, G; Ramaswami, U; ... Mehta, AB; + view all (2007) Fabry disease and the skin: data from FOS, the Fabry outcome survey. British Journal of Dermatology , 157 (2) pp. 331-337. 10.1111/j.1365-2133.2007.08002.x.

Osman, E; Graham, I; Athanasopoulos, T; Nathwani, AC; Owen, JS; (2007) Liver-directed gene transfer of atheroprotective human ApoA-I-Milano. In: HUMAN GENE THERAPY. (pp. 967 - 967). MARY ANN LIEBERT INC

P

Peggs, KS; Quezada, SA; Simpson, TR; Allison, JP; (2007) Dissociation of systemic and local anti-tumor immunity following depletion of regulatory T cells limits therapeutic activity in established tumors. In: BLOOD. (pp. 91A - 91A). AMER SOC HEMATOLOGY

Peggs, KS; Segal, NH; Allison, JP; (2007) Targeting immunosupportive cancer therapies: Accentuate the positive, eliminate the negative. CANCER CELL , 12 (3) 192 - 199. 10.1016/j.ccr.2007.08.023.

Peggs, KS; Sureda, A; Qian, W; Caballero, D; Hunter, A; Urbano-Ispizua, A; Cavet, J; ... UK Spanish Collaborative Grps, ; + view all (2007) Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes. BRIT J HAEMATOL , 139 (1) 70 - 80. 10.1111/j.1365-2141.2007.06759.x.

Petersdorf, E; Bardy, P; Cambon-Thomsen, A; Goulmy, E; Hansen, J; Schwarer, A; Velardi, A; (2007) 14thInternational HLA and Immunogenetics Workshop: report on hematopoietic cell transplantation. Tissue Antigens , 69 Sup pp. 17-24. 10.1111/j.1399-0039.2006.759_1.x.

Popat, R; Oakervee, H; Curry, N; Odeh, L; Foot, N; Esseltine, DL; Drake, M; ... Cavenagh, JD; + view all (2007) Long term follow-up of PAD for untreated multiple myeloma. In: (Proceedings) 11th International Myeloma Workshop/4th International Workshop on Wladenestroms Macroglobulinemia. (pp. pp. 181-182). FERRATA STORTI FOUNDATION Gold open access

Popat, R; Williams, C; Cook, M; Craddock, C; Basu, S; Singer, C; Odeh, L; ... Cavenagh, JD; + view all (2007) Bortezomib, low dose intravenous melphalan and dexamethasone for patients with relapsed multiple myeloma: Final results of a phase I/II clinical trial. In: (Proceedings) 49th Annual Meeting of the American-Society-of-Hematology. (pp. 796A-796A). AMER SOC HEMATOLOGY

Popat, R; Williams, C; Cook, M; Craddock, C; Basu, S; Singeri, C; Gurnbleton, T; ... Cavenagh, J; + view all (2007) Bortezomib, low dose intravenous melphalan and dexamethasone for patients with relapsed multiple myeloma: results of a phase I/II clinical trial. In: (Proceedings) 47th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 60-61). BLACKWELL PUBLISHING

Porter, J; (2007) Clinical Evaluation of Deferasirox (Exjade®, ICL670). Seminars in Hematology , 44 (SUPPL. 3) 10.1053/j.seminhematol.2007.03.004.

Porter, J; (2007) Clinical evaluation of deferasirox (Exjade (R), ICL670). SEMINARS IN HEMATOLOGY , 44 (2) S16 - S20. 10.1053/j.seminhematol.2007.03.004.

Porter, JB; (2007) Concepts and goals in the management of transfusional iron overload. AMERICAN JOURNAL OF HEMATOLOGY , 82 (12) 1136 - 1139. 10.1002/ajh.21100.

Porter, JB; (2007) Concepts and goals in the management of transfusional iron overload. American Journal of Hematology , 82 (12 SUPPL) pp. 1136-1139. 10.1002/ajh.21100.

Porter, JB; Cohen, AR; Ford, JM; Cappellini, MD; (2007) Impact of dose adjustments on serum ferritin (SF) levels during long-term treatment with once-daily, oral deferasirox (Exjade (R), ICL670). In: BLOOD. (pp. 816A - 817A). AMER SOC HEMATOLOGY

Posthouwer, D; Makris, M; Yee, TT; Fischer, K; van Veen, JJ; Griffioen, A; van Erpecum, KJ; (2007) Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study. BLOOD , 109 (9) 3667 - 3671. 10.1182/blood-2006-08-038349.

Posthouwer, D; Yee, TT; Makris, M; Fischer, K; Griffioen, A; van Veen, JJ; Mauser-Bunschoten, EP; (2007) Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders: an international, multicenter cohort study. J THROMB HAEMOST , 5 (8) 1624 - 1629.

Prieto-Hinojosa, A; Madrigal, JA; Shaw, B; Mayor, NP; Maldonado-Torres, H; Marsh, SGE; Travers, P; (2007) High recipient levels of natural regulatory T-cells prior to unrelated donor haematopoietic stem cell transplantation predict for an increased risk of disease relapse and poorer disease-free and overall survival. In: (Proceedings) 33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation. (pp. S32-S33). NATURE PUBLISHING GROUP

Prieto-Hinojosa, A; Madrigal, JA; Shaw, BE; Mayor, NP; Marsh, SGE; Travers, P; Duarte, RF; (2007) High recipient CD4(+)CD25(HI) regulatory T-cell level pre-transplant is associated with reduced overall survival after unrelated donor hematopoyetic stem cell transplantation. In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. (pp. 5 - 5). ELSEVIER SCIENCE INC

Q

Quinn, J; Brooks, R; Walker, F; Peebles, D; Cohen, H; (2007) Dose-escalated low molecular weight heparin provides effective anticoagulation for women with mechanical heart valves during pregnancy: A single-centre experience. In: BLOOD. (pp. 554A - 555A). AMER SOC HEMATOLOGY

Quinn, J; Mohamedbhai, S; Treacey, M; D'Sa, S; Nathwani, A; (2007) Rituximab in combination with high-dose steroids in advanced, refractory chronic lymphocytic leukaemia. In: BLOOD. (pp. 253B - 253B). AMER SOC HEMATOLOGY

R

Rabin, N; Coulton, L; Gallagher, OM; Benjamin, R; Singh, N; McIntosh, JH; Buckle, C; ... Yong, K; + view all (2007) Micro-computer tomography (MICROCT) analysis demonstrates extensive bone loss in the KMS-12-BM xenogeneic murine model of myeloma. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 136 - 136). FERRATA STORTI FOUNDATION Gold open access

Rabin, N; D'Sa, S; Symeonidis, A; Kyriakou, C; Dangwa, F; Ward, L; Yong, K; (2007) Consolidation treatment with cyclophosphamide, dexamethasone and thalidomide following autologous stem cell transplantation is safe, well tolerated and improves depth of response. In: (Proceedings) 11th International Myeloma Workshop/4th International Workshop on Waldenstroms Macroglobulinemia. (pp. p. 194). FERRATA STORTI FOUNDATION

Rabin, N; Kyriakou, C; Coulton, L; Gallagher, OM; Buckle, C; Benjamin, R; Singh, N; ... Yong, KL; + view all (2007) A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transfer. LEUKEMIA , 21 (10) 2181 - 2191. 10.1038/sj.leu.2404814.

Ramanujachar, R; Richards, S; Hann, I; Goldstone, A; Mitchell, C; Vora, A; Rowe, J; (2007) Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. PEDIATR BLOOD CANCER , 48 (3) 254 - 261. 10.1002/PBC.20749.

Rao, AG; Ancliff, PJ; Webb, DK; Linch, DC; Gale, RE; (2007) The occurrence of mutations in PTPN11 and KRAS is not dissimilar in patients with indolent juvenile myelomonocytic leukemia (JMML) from those with clinically more aggressive disease. In: BLOOD. (pp. 715A - 715A). AMER SOC HEMATOLOGY

Rasaiyaah, J; Yong, K; Katz, DR; Kellam, P; Chain, BM; (2007) Dendritic cells and myeloid leukaemias: plasticity and commitment in cell differentiation. BRIT J HAEMATOL , 138 (3) 281 - 290. 10.1111/j.1365-2141.2007.06622.x.

Ries, M; Clarke, JT; Whybra, C; Mehta, A; Loveday, KS; Brady, RO; Beck, M; (2007) Enzyme replacement in Fabry disease: pharmacokinetics and pharmacodynamics of agalsidase alpha in children and adolescents. The Journal of Clinical Pharmacology , 47 (10) pp. 1222-1230. 10.1177/0091270007305299.

Riva, A; Paulon, E; Nathwani, A; Taylor, J; Naoumov, NV; (2007) Adenovirus-mediated delivery of HBV DNA in dendritic cells: A potent approach to overcome impaired T-cell reactivity in chronic hepatitis B. In: JOURNAL OF HEPATOLOGY. (pp. S158 - S159). ELSEVIER SCIENCE BV

Roberts, CH; Madrigal, JA; Marsh, SGE; (2007) Cloning and sequencing alleles of the KIR2DL4 gene from genomic DNA samples. TISSUE ANTIGENS , 69 pp. 88-91. 10.1111/j.1399-0039.2006.762_2.x.

Roberts, CH; Turino, C; Madrigal, JA; Marsh, SGE; (2007) Enrichment of individual KIR2DL4 sequences from genomic DNA using long-template PCR and allele-specific hybridization to magnetic bead-bound oligonucleotide probes. TISSUE ANTIGENS , 69 (6) pp. 597-601. 10.1111/j.1399-0039.2007.00818.x.

Robinson, J; Marsh, SGE; (2007) The IMGT/HLA database. In: UNSPECIFIED (pp. 43-60).

Robinson, J; Marsh, SGE; (2007) IPD: the Immuno Polymorphism Database. In: UNSPECIFIED (pp. 61-74).

Romero, MAB; Deegan, P; Baehner, F; Hughes, D; Beck, M; European FOS Investigators Grp, ; (2007) Differences in the severity of the manifestations of Fabry disease in females according to geographical location in Europe. ACTA PAEDIATR , 96 94 - 95.

S

Sandmaier, BM; Mackinnon, S; Childs, RW; (2007) Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: Current perspectives. BIOL BLOOD MARROW TR , 13 (1) 87 - 97. 10.1016/j.bbmt.2006.10.015.

Scully, M; Cavenagh, J; Hunt, B; Cohen, H; Machin, SJ; (2007) A phase II study to assess the safety, efficacy and tolerability of rituximab in combination with plasma exchange in patients with acute idiopathic thrombotic thrombocytopenic purpura. In: BLOOD. (pp. 392A - 392A). AMER SOC HEMATOLOGY

Scully, M; Cohen, H; Cavenagh, J; Benjamin, S; Starke, R; Killick, S; Mackie, I; (2007) Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. BRIT J HAEMATOL , 136 (3) 451 - 461. 10.1111/j.1365-2141.2006.06448.x.

Shah, F.T.; (2007) The relationship between non transferrin bound iron and iron overload in thalassaemia and sickle syndromes. Doctoral thesis , University of London. Green open access
file

Shah, JS; Hughes, D; Tayebjee, M; MacFadyen, R; Mehta, A; Elliott, PM; (2007) Extracellular matrix turnover and disease severity in Anderson–Fabry disease. In: (pp. pp. 118-123).

Shah, JS; Hughes, DA; Tayebjee, MH; MacFadyen, RJ; Mehta, AB; Elliott, PM; (2007) Extracellular matrix turnover and disease severity in Anderson-Fabry disease. J INHERIT METAB DIS , 30 (1) 88 - 95. 10.1007/s10545-006-0360-6.

Shaw, BE; Boswell, T; Byrne, JL; Yates, C; Russell, NH; (2007) Clinical impact of MRSA in a stem cell transplant unit: analysis before, duringand after an MRSA outbreak. BONE MARROW TRANSPL , 39 (10) 623 - 629. 10.1038/sj.bmt.1705654.

Shaw, BE; Byrne, JL; Das-Gupta, E; Carter, GI; Russell, NH; (2007) The impact of chimerism patterns and predonor leukocyte infusion lymphopenia on survival following T cell-depleted reduced intensity conditioned transplants. BIOL BLOOD MARROW TR , 13 (5) 550 - 559. 10.1016/j.bbmt.2006.12.451.

Shaw, BE; Gooley, T; Madrigal, JA; Malkki, M; Marsh, SGE; Petersdorf, EW; (2007) Clinical Importance of HLA-DPB1 in Haematopoietic Cell Transplantation (HCT). Tissue Antigens , 69 (Suppl 1) pp. 36-41.

Shaw, BE; Gooley, T; Madrigal, JA; Malkki, M; Marsh, SGE; Petersdorf, EW; IHWG HCT Component, ; (2007) Clinical importance of HLA-DPB1 in haematopoietic cell transplantation. TISSUE ANTIGENS , 69 36 - 41. 10.1111/j.1399-0039.2006.759_4.x.

Shaw, BE; Gooley, TA; Malkki, M; Madrigal, JA; Begovich, AB; Horowitz, MM; Gratwohl, A; ... Petersdorf, EW; + view all (2007) The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. BLOOD , 110 (13) 4560 - 4566. 10.1182/blood-2007-06-095265.

Shaw, BE; Mayor, NP; Little, AM; Russell, NH; Pagliuca, A; Ethell, ME; Morgan, GJ; ... Marsh, SGE; + view all (2007) Matching for 12 HLA alleles is associated with a significantly superior survival due to a lower mortality in recipients of unrelated donor haematopoietic cell transplants for early but not late stage leukaemia. In: BLOOD. (pp. 898A - 898A). AMER SOC HEMATOLOGY

Shaw, BE; Russell, NH; Pagliuca, A; Apperley, J; Cook, G; Mackinnon, S; Madrigal, JA; ... Byrne, JL; + view all (2007) A comparison of stem cell source in recipients of T-Cell depleted myeloablative transplants for leukaemia: No difference in mortality using BM or PBSC. In: BLOOD. (pp. 22A - 22A). AMER SOC HEMATOLOGY

Smith, BN; Ancliff, PJ; Linch, DC; Gale, RE; (2007) Identification of two novel homozygous HAX1 mutations in an autosomal recessive Jewish and two unrelated sporadic British families with severe congenital neutropenia. In: BLOOD. (pp. 972A - 972A). AMER SOC HEMATOLOGY

Sodi, A; Ioannidis, AS; Mehta, A; Davey, C; Beck, M; Pitz, S; (2007) Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey. British Journal of Ophthalmology , 91 (2) pp. 210-214.

Srichairatanakool, S; Thephinlap, C; Phisalaphong, C; Porter, JB; Fucharoen, S; (2007) Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma. MED CHEM , 3 (5) 469 - 474.

Starke, R; Machin, S; Scully, M; Purdy, G; Mackie, I; (2007) The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura. BRIT J HAEMATOL , 136 (4) 649 - 655. 10.1111/j.1365-2141.2006.06471.x.

Starke, R; Machin, S; Scully, M; Purdy, G; Mackie, I; (2007) The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura. Br J Haematol , 136 (4) pp. 649-655. 10.1111/j.1365-2141.2006.06471.x.

Starke, R; Mackie, I; Lawrie, A; Scully, M; Machin, S; (2007) FXI/ADAMTS13 complex in TTP and factor XI deficient patients. INT J LAB HEMATOL , 29 77 - 77.

Steele, AJ; Prentice, A; Cwynarski, K; Hoffbrand, AV; Wickremasinghe, RG; (2007) 2-phenylacetylenesulfonamide upregulates Noxa and induces p53-independent apoptosis of CLL cells. In: BLOOD. (pp. 480A - 481A). AMER SOC HEMATOLOGY

Steele, AJ; Prentice, A; Cwynarski, K; Hoffbrand, AV; Wickremasinghe, RG; (2007) Pifithrin alpha, a selective inhibitor of p53-mediated transcription, augments apoptotic killing of chronic lymphocytic leukemia cells by nutlin 3a and cytotoxic drugs. In: BLOOD. (pp. 475A - 475A). AMER SOC HEMATOLOGY

Swerdlow, A.J.; Higgins, C.D.; Smith, P.; Cunningham, D.; Hancock, B.W.; Horwich, A.; Hoskin, P.J.; ... Linch, D.C.; + view all (2007) Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. JNCI Journal of the National Cancer Institute , 99 (3) pp. 206-214. 10.1093/jnci/djk029.

Swerdlow, AJ; Higgins, CD; Smith, P; Cunningham, D; Hancock, BW; Horwich, A; Hoskin, PJ; ... Linch, DC; + view all (2007) Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study. J NATL CANCER I , 99 (3) 206 - 214. 10.1093/jnci/djk029.

Swerdlow, AJ; Higgins, CD; Smith, P; Cunningham, D; Hancock, BW; Horwich, A; Hoskin, PJ; ... Linch, DC; + view all (2007) Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 1 - 1). FERRATA STORTI FOUNDATION Gold open access

Symeonidis, A; Richfield, L; Miligan, A; Bruce, R; Hughes, D; Mehta, A; (2007) Achievement of the goals of therapy for patients with Gaucher disease on enzyme replacement therapy is higher among earlier-treated patients and is not influenced by disease severity at presentation. Presented at: 12th Congress of the European-Hematology-Association, Vienna, AUSTRIA.

T

Taher, A; Nathan, D; Porter, J; (2007) Evaluation of Iron Levels to Avoid the Clinical Sequelae of Iron Overload. Seminars in Hematology , 44 (SUPPL. 3) 10.1053/j.seminhematol.2007.03.002.

Taher, A; Nathan, D; Porter, J; (2007) Evaluation of iron levels to avoid the clinical sequelae of iron overload. SEMINARS IN HEMATOLOGY , 44 (2) S2 - S6. 10.1053/j.seminhematol.2007.03.002.

Tappenden, KA; Evans, G; Gallimore, MJ; Mackie, IJ; Wendel, HP; Winter, M; Jones, DW; (2007) Incorporation of human microvascular enclothelial cells into the whole blood thrombin generation assay. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 14 - 14). BLACKWELL PUBLISHING

Tappenden, KA; Evans, G; Gallimore, MJ; Mackie, IJ; Winter, M; Jones, DW; (2007) Thrombin generation: a comparison of assays using platelet poor and platelet rich plasma and whole blood samples from healthy control subjects and patients with a history of venous thromboembolism. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 41 - 41). BLACKWELL PUBLISHING

Tappenden, KA; Evans, G; Gallimore, MJ; Mackie, IJ; Winter, M; Jones, DW; (2007) Whole blood thrombin and thromboelastography 'thrombus' generation assays: a comparative study in healthy control subjects and patients with a history of venous thromboembolism. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 15 - 15). BLACKWELL PUBLISHING

Tappenden, KA; Gallimore, MJ; Evans, G; Mackie, IJ; Jones, DW; (2007) Thrombin generation: a comparison of assays using platelet-poor and -rich plasma and whole blood samples from healthy controls and patients with a history of venous thromboembolism. BRIT J HAEMATOL , 139 (1) 106 - 112. 10.1111/j.1365-2141.2007.06732.x.

Taylor, C; Cohen, H; Jones, H; (2007) The 2006 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Thephinlap, C; Ounjaijean, S; Khansuwan, U; Fucharoen, S; Porter, JB; Srichairatanakool, S; (2007) Epigallocatechin-3-gallate and epicatechin-3-gallate from green tea decrease plasma non-transferrin bound iron and erythrocyte oxidative stress. MED CHEM , 3 (3) 289 - 296.

Thomson, K; Morris, E; Bloor, A; Cook, G; Milligan, D; Parker, A; Craddock, C; ... Mackinnon, S; + view all (2007) Long-term follow-up of reduced intensity transplantation with an alemtuzumab-containing regimen for aggressive non-Hodgkins lymphoma. In: BLOOD. (pp. 495A - 496A). AMER SOC HEMATOLOGY

Thomson, K; Morris, E; Milligan, D; Hunter, A; Cook, G; Bloor, A; Craddock, C; ... Mackinnon, S; + view all (2007) Extended follow-up of reduced intensity transplantation with an alemtuzumab-containing regimen for follicular lymphoma. In: BLOOD. (pp. 497A - 497A). AMER SOC HEMATOLOGY

Thomson, KJ; Mackinnon, S; Peggs, KS; (2007) T-cell depleted haematopoietic stem cell transplantation and salvage donor lymphocyte infusions. In: Davenport, LP, (ed.) Stem cell research advances. (pp. 111-136). Nova Biomedical

Thomson, KJ; Peggs, KS; Blundell, E; Goldstone, AH; Linch, DC; (2007) A second autologous transplant may be efficacious in selected patients with Hodgkin's lymphoma relapsing after a previous autograft. LEUKEMIA LYMPHOMA , 48 (5) 881 - 884. 10.1080/10428190701216394.

Tsuzuki, S; Seto, M; Hong, D; Gupta, R; Enver, T; Matsuo, K; (2007) Isoform-specific potentiation of stem and progenitor cell engraftment by AML1/RUNX1. PLoS Medicine , 4 (5) , Article e172. 10.1371/journal.pmed.0040172. Green open access
file

V

Vaessen, SFC; Comijn, L; Snapper, J; Nathwani, AC; Kastelein, J; Petry, H; Kuivenhoven, JA; (2007) Correction of HDL deficiency in ApoA-I-deficient mice following self-complementary AAV-mediated liver expression of human ApoA-I. In: HUMAN GENE THERAPY. (pp. 982 - 982). MARY ANN LIEBERT INC

Vasilcan, M; O'Brien, F; Sekhavat, M; Mackinnon, S; Lowdell, MW; (2007) Clean-room conditions for HPC processing have no impact on incidence of product contamination or on clinical outcome. In: BONE MARROW TRANSPLANTATION. (pp. S179 - S180). NATURE PUBLISHING GROUP

Vezzalini, M; Mombello, A; Menestrina, F; Mafficini, A; Della Peruta, M; van Niekerk, C; Barbareschi, M; ... Sorio, C; + view all (2007) Expression of transmembrane protein tyrosine phosphatase gamma (PTP gamma) in normal and neoplastic human tissues. HISTOPATHOLOGY , 50 (5) 615 - 628. 10.1111/j.1365-2559.2007.02661.x.

Vichinsky, E; Onyekwere, O; Porter, J; Swerdlow, P; Eckman, J; Lane, P; Files, B; ... Coates, T; + view all (2007) A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. BRITISH JOURNAL OF HAEMATOLOGY , 136 (3) pp. 501-508. 10.1111/j.1365-2141.2006.06455.x.

Virappane, P; Gale, RE; Hills, R; Kakkas, I; Summers, K; Stevens, J; Green, C; ... Fitzgibbon, J; + view all (2007) Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemoresistance in normal karyotype acute myeloid leukemia. In: BLOOD. (pp. 113A - 113A). AMER SOC HEMATOLOGY

Virappane, P; Gale, RE; Hills, RK; Kakkas, K; Summers, K; Stevens, J; Green, CL; ... Fitzgibbon, J; + view all (2007) Wilms' tumour 1 mutation in normal karyotype aml. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 19 - 20). FERRATA STORTI FOUNDATION Gold open access

W

Walter, PB; Porter, J; Evans, P; Kwiatkowski, JL; Neufeld, EJ; Coates, T; Giardina, PJ; ... Harmatz, P; + view all (2007) Leukocyte apoptosis and mitochondrial dysfunction in beta-thalassemia patients treated with deferasirox or deferoxamine. In: BLOOD. (pp. 815A - 815A). AMER SOC HEMATOLOGY

Ward, N; Apolonia, L; Fernandes, C; Waddington, S; Cochrane, M; Kinnon, C; Thrasher, A; ... Philpott, N; + view all (2007) Non-integrating lentiviral vector pseudotypes for safer gene therapy. In: HUMAN GENE THERAPY. (pp. 1038 - 1038). MARY ANN LIEBERT INC

Wedderburn, L.R.; Varsani, H.; Li, C.K.C.; Newton, K.R.; Amato, A.A.; Banwell, B.; Bove, K.E.; ... Holton, J.L.; + view all (2007) International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis & Rheumatism , 57 (7) pp. 1192-1201. 10.1002/art.23012.

Westwood, MA; Anderson, LJ; Maceira, AM; Shah, FT; Prescott, E; Porter, JB; Wonke, B; ... Pennell, DJ; + view all (2007) Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron. JOURNAL OF MAGNETIC RESONANCE IMAGING , 25 (6) pp. 1147-1151. 10.1002/jmri.20915.

Westwood, MA; Shah, F; Anderson, LJ; Strange, JW; Tanner, MA; Maceira, AM; Howard, J; ... Pennell, DJ; + view all (2007) Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy. J MAGN RESON IMAGING , 26 (3) 564 - 568. 10.1002/jmri.21018.

Wiener, E; Rafique, R; Mascarenhas, M; Srai, K; Porter, JB; (2007) Heme and non-heme iron loading of human hepatocyte-like cells (HUH7) have contrasting effects on labile intracellular iron and NTBI uptake but show similar down-regulation of hepcidin synthesis: Implications for iron distribution in iron overload. AM J HEMATOL , 82 (6) 543 - 543.

Williamson, LM; Stainsby, D; Jones, H; Love, E; Chapman, CE; Navarrete, C; Lucas, G; ... Cohen, H; + view all (2007) The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease. Transfusion , 47 pp. 1455-1467.

Williamson, LM; Stainsby, D; Jones, H; Love, E; Chapman, CE; Navarrete, C; Lucas, G; ... Serious Hazards Transfusion Steeri, ; + view all (2007) The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease. TRANSFUSION , 47 (8) 1455 - 1467. 10.1111/j.1537-2995.2007.01281.x.

Williamson, LM; Stainsby, D; Jones, H; Love, EM; Chapman, CE; Caspard, A; Cohen, H; (2007) Reports to the serious hazards of transfusion (SHOT) scheme of post-transfusion purpura (PTP) and transfusion-associated graft-versus-host disease (TA-GvHD) before and after implementation of universal leucodepletion in the UK. In: (Proceedings) British society for haematology annual scientific meeting.

Y

Yamaguchi, M; Fujimura, K; Toga, H; Khwaja, A; Okamura, N; Chopra, R; (2007) Shwachman-Diamond Syndrome is not necessary for the terminal maturation of neutrophils but is important for maintaining viability of granulocyte precursors. EXP HEMATOL , 35 (4) 579 - 586. 10.1016/j.exphem.2006.12.010.

Yun, G; Tolar, J; Yerich, AK; Marsh, SGE; Robinson, J; Noreen, H; Blazar, BR; (2007) A novel method for KIR-ligand typing by pyrosequencing to predict NK cell alloreactivity. CLINICAL IMMUNOLOGY , 123 (3) pp. 272-280. 10.1016/j.clim.2007.01.011.

Z

Zhang, S-Y; Jouanguy, E; Ugolini, S; Smahi, A; Elain, G; Romero, P; Segal, D; ... Casanova, J-L; + view all (2007) TLR3 deficiency in patients with herpes simplex encephalitis. SCIENCE , 317 (5844) pp. 1522-1527. 10.1126/science.1139522.

This list was generated on Sun May 19 04:44:14 2019 BST.